S

Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399

Watchlist Manager
Shenzhen Hepalink Pharmaceutical Group Co Ltd
SZSE:002399
Watchlist
Price: 10.99 CNY -2.74%
Market Cap: 13.7B CNY
Have any thoughts about
Shenzhen Hepalink Pharmaceutical Group Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Shenzhen Hepalink Pharmaceutical Group Co Ltd

Wall Street analysts forecast Shenzhen Hepalink Pharmaceutical Group Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shenzhen Hepalink Pharmaceutical Group Co Ltd is 7.45 CNY with a low forecast of 7.37 CNY and a high forecast of 7.67 CNY.

Lowest
Price Target
7.37 CNY
33% Downside
Average
Price Target
7.45 CNY
32% Downside
Highest
Price Target
7.67 CNY
30% Downside
Shenzhen Hepalink Pharmaceutical Group Co Ltd Competitors:
Price Targets
4015
Jamjoom Pharmaceuticals Factory Company SJSC
13% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
16% Upside
AJANTPHARM
Ajanta Pharma Ltd
7% Upside
600750
Jiang Zhong Pharmaceutical Co Ltd
38% Upside
PLTH
Planet 13 Holdings Inc
184% Upside
ZTS
Zoetis Inc
35% Upside
SHILPAMED
Shilpa Medicare Ltd
100% Upside
TORNTPHARM
Torrent Pharmaceuticals Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
Shenzhen Hepalink Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Hepalink Pharmaceutical Group Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 8%.

11%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shenzhen Hepalink Pharmaceutical Group Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Net Income
Forecast

Net Income Estimate
Shenzhen Hepalink Pharmaceutical Group Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's stock price target?
Price Target
7.45 CNY

According to Wall Street analysts, the average 1-year price target for Shenzhen Hepalink Pharmaceutical Group Co Ltd is 7.45 CNY with a low forecast of 7.37 CNY and a high forecast of 7.67 CNY.

What is Shenzhen Hepalink Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Shenzhen Hepalink Pharmaceutical Group Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 8%.

Back to Top